Bck Capital Management »

Cerevel Therapeutics Hldng I shares owned by Bck Capital Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Bck Capital Management from 13F filings

Historical chart of Bck Capital Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Bck Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Bck Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $933k 22k 42.40

More positions owned by Bck Capital Management

Endeavor Group Hldgs Cl A Com (EDR)
PGT
Albertsons Cos Common Stock (ACI)
stock
Capri Holdings SHS (CPRI)
Willscot Mobil Mini Hldng Com Cl A (WSC)
Alteryx Com Cl A
Pioneer Natural Resources (PXD)
Olink Hldg Ab Sponsored Ads (OLK)
Sp Plus (SP)
Textainer Group Holdings SHS
Spirit Rlty Cap Com New
Capstar Finl Hldgs (CSTR)
Westrock (WRK)
Euronav Nv SHS (EURN)

View all positions for Bck Capital Management

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I